BIOMAT Database Logo BIOMAT Database Logo

[Catecholamine, DOPA and vanilmandelic acid excretion in healthy subjects and depression patients of presenile age]. 1978

L A Kryzhanovskaia, and L S Usherenko

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014642 Vanilmandelic Acid A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE. Methoxyhydroxymandelic Acid,4-Hydroxy-3-Methoxymandelic Acid,Vanillylmandelic Acid,4 Hydroxy 3 Methoxymandelic Acid,Acid, 4-Hydroxy-3-Methoxymandelic,Acid, Methoxyhydroxymandelic,Acid, Vanillylmandelic,Acid, Vanilmandelic

Related Publications

L A Kryzhanovskaia, and L S Usherenko
[Catecholamine and vanilmandelic acid excretion in patients with diabetes mellitus].
January 1979, Endokrynologia Polska,
L A Kryzhanovskaia, and L S Usherenko
[Catecholamine excretion (vanilmandelic acid, VMS, and homovanillic acid, HVS) in urine of healthy children].
August 1983, Kinderarztliche Praxis,
L A Kryzhanovskaia, and L S Usherenko
[Excretion of catecholamines, their precursor DOPA and vanilmandelic acid in patients with peptic ulcer].
August 1983, Vrachebnoe delo,
L A Kryzhanovskaia, and L S Usherenko
[Catecholamine metabolism and clinical significance of homovanillic and vanilmandelic acid excretion].
February 1969, Voprosy okhrany materinstva i detstva,
L A Kryzhanovskaia, and L S Usherenko
[Peripheral resistance and excretion of vanilmandelic acid in hypertensive subjects].
August 1970, Bollettino della Societa italiana di biologia sperimentale,
L A Kryzhanovskaia, and L S Usherenko
Vanilmandelic acid excretion in cancer patients.
December 1969, Annals of clinical research,
L A Kryzhanovskaia, and L S Usherenko
[Catecholamine and DOPA excretion in peptic ulcer patients].
January 1973, Voprosy meditsinskoi khimii,
L A Kryzhanovskaia, and L S Usherenko
[Excretion of 5-hydroxyindoleacetic acid and vanilmandelic acid in patients with glaucoma].
May 1967, Ceskoslovenska oftalmologie,
L A Kryzhanovskaia, and L S Usherenko
[Excretion of 3-methoxy-4-hydroxymandelic acid (vanilmandelic acid), a principal catecholamine metabolite, in pregnancy and late gestoses].
October 1965, Ceskoslovenska gynekologie,
L A Kryzhanovskaia, and L S Usherenko
Excretion of vanilmandelic acid in the urine of retinoblastoma patients.
January 1979, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
Copied contents to your clipboard!